bladder cancer. Malignant neoplasm of bladder
Conditions
Interventions
Intervention 1: Intervention group: two doses (20 mg every doses and total 40 mg) deep intramuscular long acting Sandostatin two weeks before surgery and just before surgery. After cystectomy, a speci
Treatment - Drugs
Treatment - Surgery
Intervention group: two doses (20 mg every doses and total 40 mg) deep intramuscular long acting Sandostatin two weeks before surgery and just before surgery. After cystectomy, a specimen from proxima
Control group: after cystectomy, a specimen from proximal part of urethral is taken and sent for Frozen section and if the specimen will negative, neobladder will created with 40 cm of ileum, internal
Sponsors
Vice Chancellery of Research of Isfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: invasive bladder carcinoma, no urethral involvement, patient consent to perform surgery in this manner Exclusion criteria: urethral involvement in frozen section
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 24-hour urine Mucous volume. Timepoint: on days seven and twenty one after surgery. Method of measurement: 24-hour urine was collected and its mucus volume in gram was recorded. | — |
Secondary
| Measure | Time frame |
|---|---|
| The number of washings. Timepoint: every 2 hours. Method of measurement: if urine flow become slow or urethral catheter blockage bladder irrigation is done & number of washings was recorded.;Average time for drying of dressing. Timepoint: daily visit. Method of measurement: with daily visit and scale day from surgery. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamidreza Zia
Isfahan University of Medical Sciences
Outcome results
None listed